
Meto HT 50mg/12.5mg Tablet ER
Marketer
Mano Pharma Pvt Ltd
Salt Composition
Metoprolol Succinate (50mg) + Hydrochlorothiazide (12.5mg)
Overview Meto HT 50mg/12.5mg Tablet ER
CardioControl ER 50mg/12.5mg tablets manage hypertension (high blood pressure) when a single drug proves insufficient. This medication helps control blood pressure, lowering the risk of future heart attacks and strokes. Early use improves survival rates following a heart attack. CardioControl ER is taken once daily, preferably in the morning, with or without food, to minimize nighttime urination. Continue treatment as directed by your physician; discontinuing prematurely, even if feeling well, can worsen your condition as hypertension often lacks symptoms. Lifestyle modifications, such as regular exercise, weight management, and a balanced diet, further enhance blood pressure control. Adhere strictly to your doctor's instructions. Common side effects include nausea, constipation, diarrhea, and fatigue. Report any persistent, worsening, or bothersome side effects to your doctor. Increase fluid intake to alleviate potential muscle weakness, dry mouth, or thirst. Dizziness or headaches, possibly indicative of low blood pressure, may occur; rise slowly from a seated position and avoid driving if affected. Inform your physician of any pre-existing liver or kidney conditions before commencing treatment. Pregnant or breastfeeding individuals should seek medical counsel prior to use. Always disclose all current medications, particularly those for hypertension or cardiac issues. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium and magnesium) is crucial to ensure treatment efficacy.
Uses of Meto HT 50mg/12.5mg Tablet ER
Elevated blood pressure
Major Benefits of Meto HT 50mg/12.5mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meto HT 50mg/12.5mg Extended-Release tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Meto HT 50mg/12.5mg Tablet ER:
- Fatigue
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Meto HT 50mg/12.5mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meto HT 50mg/12.5mg Extended-Release Tablets can be administered with or without food, however, consistent daily timing is recommended.
How Meto HT 50mg/12.5mg Tablet ER works:
Meto-HT 50mg/12.5mg Extended-Release tablets contain a dual-action formulation for blood pressure management. This combines metoprolol succinate, a beta-blocker that moderates heart rate and improves cardiac output, with hydrochlorothiazide, a diuretic promoting fluid excretion and electrolyte balance. The diuretic effect also contributes to vasodilation and enhanced circulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Meto HT 50mg/12.5mg ER tablet use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Extended-release Meto HT 50mg/12.5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Meto HT 50mg/12.5mg tablets are likely safe for breastfeeding mothers. Available evidence from human studies indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Meto HT 50mg/12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when prescribing Meto HT 50mg/12.5mg Tablet ER to individuals with severely impaired renal function. Dosage modification of Meto HT 50mg/12.5mg Tablet ER may be necessary. Physician consultation is advised. Meto HT 50mg/12.5mg Tablet ER is generally contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Meto HT 50mg/12.5mg Extended-Release tablets cautiously. Dosage modification of Meto HT 50mg/12.5mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Meto HT 50mg/12.5mg Tablet ER :
Should you forget to take a Meto HT 50mg/12.5mg Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Meto HT 50mg/12.5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
